Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
9.69
-0.10 (-1.02%)
Nov 21, 2024, 4:00 PM EST - Market closed

Neumora Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
124
Market Cap
1.57B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Clover Health Investments 2.12B
GoodRx Holdings 790.39M
10x Genomics 629.74M
Certara 372.80M
Immunocore Holdings 296.31M
Dynavax Technologies 260.81M
Arvinas 161.10M
Xencor 85.16M
Revenue Rankings